AcelRx Pharmaceuticals, Inc. closed a private placement agreement with several institutional investors, selling various shares and warrants, making a total of around $10.0 million before placement agent fees and expenses. If all warrants are fully exercised for cash, the potential gross proceeds could reach approximately $16.3 million.